GALENA BIOPHARMA INC - COM (GALE)

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
31,557,634
Share change
+9,592,462
Total reported value
$43,865,108
Put/Call ratio
55%
Price per share
$1.39
Number of holders
83
Value change
+$13,281,966
Number of buys
48
Number of sells
25

Institutional Holders of GALENA BIOPHARMA INC - COM (GALE) as of Q1 2015

As of 31 Mar 2015, GALENA BIOPHARMA INC - COM (GALE) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,557,634 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, HIGHLAND CAPITAL MANAGEMENT LP, SABBY MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Bank of New York Mellon Corp. This page lists 83 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.